Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2003
12/17/2003EP1094794B1 Dry-copying method for producing flat, individually dosed preparations of active agents
12/17/2003EP1079918B1 Microencapsulation and electrostatic processing method
12/17/2003EP1032370B1 Porous hydroxyapatite particles as carriers for drug substances
12/17/2003EP1028715B1 Dosage composition for nasal delivery comprising vibrio cholera zonula occludens toxin as absorption enhancer
12/17/2003EP0980241B1 Gelatine encapsulated solution dosage forms of sertraline
12/17/2003EP0974355B1 Water-soluble vitamin composition that provides excellent tablets and process for producing the same
12/17/2003EP0939624B1 Effervescent bisphosphonate formulation
12/17/2003EP0871430B1 Powders and their use in dry powder inhalers
12/17/2003EP0852490B1 Emulsion formulations for the delivery of nucleic acids to cells
12/17/2003EP0836495B1 Delivery of oxygen-supersaturated physiologic solutions
12/17/2003EP0831820B1 Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
12/17/2003EP0806938B1 Powder for use in dry powder inhalers
12/17/2003CN1462310A Process for producing isomaltose and use thereof
12/17/2003CN1462194A Oral preparations and supports for oral preparations
12/17/2003CN1462193A Oral preparations
12/17/2003CN1462191A Treatment of ocute coronary syndrome with GLP-1
12/17/2003CN1462188A Compositions for regulating desire for smoking
12/17/2003CN1462187A Analgesic/antiinflammatary patches for topical use
12/17/2003CN1462186A Stable solid dosage forms of amino acids and processes for producing same
12/17/2003CN1462185A Improved transdermal therapeutic system for treatment of Parkinson's disese
12/17/2003CN1461639A Slow-releasing injection contg. hydrocastor oil/medicine (for treatment) solid dispersion microparticle
12/17/2003CN1131271C Carrangeenan compositions and process for their production
12/17/2003CN1131241C Cross-linked hyaluronic acids and medical uses thereof
12/17/2003CN1131208C Compound, their preparation and use for transferring nucleic acids into cells
12/17/2003CN1131072C Radioactive chitosan complex, its preparation method and use
12/17/2003CN1131068C Composite lysostaphin enzyme spray for oral cavity and its preparing process
12/17/2003CN1131066C Application of radix scutellariae stem and leaf for preparing medicine for analgesia, anti-flammatory/and antipyretic
12/17/2003CN1131058C Chinese medicine for treating blood viscosity and its preparing process
12/17/2003CN1131057C Chinese medicine fumigant for treating vulval disease and its prepn. method
12/17/2003CN1131055C Tincture for treating leucoderma and preparation method and application thereof
12/17/2003CN1131049C Medicine for treating psoriasis and preparation method thereof
12/17/2003CN1131045C Aloe capsule prepared from natural aloe and its preparing process
12/17/2003CN1131039C Process for preparing kelamycin injection
12/17/2003CN1131034C Novel pharmaceutical composition
12/17/2003CN1131033C Anaesthetic formulation
12/17/2003CN1131032C Benzimidzole enteric coating preparation and preparing method thereof
12/17/2003CN1131029C Application of dihydromyricetrin in medicine for preparation of hepatitis
12/17/2003CN1131028C Once-a-day methoprolol oral dosage form
12/17/2003CN1131027C Controlled release formulation for poorly soluble basic drugs
12/17/2003CN1131026C Valaciclovir tablets containing colloidal silicon dioxide
12/17/2003CN1131025C Granulate for preparation of fast-disintegrating and fast-dissolving compositions containing high amount of drug
12/17/2003CN1131024C Sustained -release matrix pellets and its preparation
12/17/2003CN1131023C Sustained release excipient
12/17/2003CN1131018C Drug-containing adhesive composite transdermal administration plaster and preparation method thereof
12/17/2003CN1130986C Health-care product for reducing blood fat and sugar and delaying sanility
12/17/2003CN1130978C Rose fruit oil capsule
12/16/2003US6665563 System and method for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment
12/16/2003US6664296 Outer envelope including gelatin, and nonaqueous liquid or semi-liquid internal phase containing spermicide, lipophilic agent compatible with rubber latex of condom, gelling agent for lipophile, hydrodispersible agent and bioadhesion agent
12/16/2003US6664294 Compounds which have excellent antimicrobial activity, even at very low concentrations, and which is retained in presence of salt-containing media, such as saline solutions
12/16/2003US6664289 Nasal solution containing a broad spectrum microbicide and a method for its use
12/16/2003US6664284 Stabilized carvedilol injection solution
12/16/2003US6664105 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
12/16/2003US6663913 Method of coating a bioactive substance
12/16/2003US6663901 Itraconazole; sugar core, a coating film of a water soluble polymer, a seal coating
12/16/2003US6663900 Processed in a fluidized bed coating machine where a protective coating of a sugar or polyhydric alcohol, starch
12/16/2003US6663899 Controlled release microencapsulated NGF formulation
12/16/2003US6663898 Carbon-substituted diketopiperazine delivery systems
12/16/2003US6663897 Oral itraconazole formulations and methods of making the same
12/16/2003US6663896 Delayed release aspirin for vascular obstruction prophylaxis
12/16/2003US6663895 Uniform crystal structure
12/16/2003US6663894 Intraocular transplantation of encapsulated cells
12/16/2003US6663893 Taste masking coating composition
12/16/2003US6663892 Multiple portion tablet
12/16/2003US6663891 Erythromyacin antibiotic product, use and formulation thereof
12/16/2003US6663890 For therapy of bacterial infection; time-release agents
12/16/2003US6663889 Ambroxol-containing lozenge
12/16/2003US6663888 Mixture of two types of beads comprising a histamine H2 receptor antagonist, immediate release beads and timed pulsatile release beads; treatment of asthma, gastric acid secretion and cardiovascular diseases
12/16/2003US6663887 Compounds and compositions for delivering active agents
12/16/2003US6663886 Inhibition of cell-cell binding by lipid assemblies
12/16/2003US6663885 Liposome system which comprises a non-toxic organic solvent and at least one phospholipid, which possesses a particularly high stability and does not lead to unwanted sedimentation.
12/16/2003US6663883 Matrix adhering to nasal mucosa
12/16/2003US6663881 Therapeutic inhibitor of vascular smooth muscle cells
12/16/2003US6663878 Anti-inflammatory bioactive glass particulates
12/16/2003US6663868 Heat shock protein-based vaccines and immunotherapies
12/16/2003US6663849 Antacid chewing gum products coated with high viscosity materials
12/16/2003US6663848 Process and apparatus for producing inhalable medicaments
12/16/2003US6663615 Dual stage microvalve and method of use
12/16/2003US6663608 Synchronizing of animal oestrus and intra vaginal devices useful therein
12/16/2003US6663555 Permanent magnet keeper-shield assembly
12/16/2003US6662805 Method for composite cell-based implants
12/16/2003CA2382275C Modafinil having defined particle size
12/16/2003CA2259297C Parenteral paclitaxel in a stable non-toxic formulation
12/16/2003CA2124578C A mixture of higher primary aliphatic alcohols, its obtention from sugar cane wax and its pharmaceutical uses
12/16/2003CA2110331C Desiccant, dehydration therewith, and dehydrated product obtainable thereby
12/16/2003CA2074495C Propellant compositions
12/14/2003CA2432231A1 Liquid antacid compositions
12/11/2003WO2003102150A2 Multi-functional polyamines for delivery of biologically-active polynucleotides
12/11/2003WO2003102116A2 Oil-soluble pigment compositions
12/11/2003WO2003102014A2 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
12/11/2003WO2003101982A1 Nicotine-containing, controlled release composition and method
12/11/2003WO2003101952A2 Polyamine-mediated transfection
12/11/2003WO2003101606A1 Method of encapsulating hydrophobic organic molecules in polyurea capsules
12/11/2003WO2003101600A2 Hazard-free microencapsulation for structurally delicate agents, an application of stable aqueous-aqueous emulsion
12/11/2003WO2003101539A1 Self-administered contraceptive injection of oily solution
12/11/2003WO2003101496A1 Methods and compositions for intravesical therapy of bladder cancer
12/11/2003WO2003101493A1 Intravenous composition, process for producing the same and preparation thereof
12/11/2003WO2003101486A2 Thermosensitive polymer carriers having a modifiable physical structure for biochemical analysis, diagnosis, and therapy
12/11/2003WO2003101483A1 Pharmaceutical preparation of botulinum neurotoxin, methods of synthesis and methods of clinical use
12/11/2003WO2003101480A1 Topical drug delivery using phosphatidylcholine
12/11/2003WO2003101479A1 Compositions for therapeutic use comprising a vitamin, a metal salt and insulin or a growth hormone